The Community Guide

- gsearch

Search Results

Narrow Results:

2018 2

Kenya 1

Journal Article 2

1 - 2 of 2 Results

Refine Results

Refine Results:

Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial

CITE Title : Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial Personal Author(s) : Kwambai, Titus K.;Dhabangi, Aggrey;Idro, Richard;Opoka, Robert;Kariuki, Simon;Samuels, Aaron M.;Desai, Meghna;van Hensbroek, Michael Boele;John, Chandy C.;Robberstad, Bjarne;Wang, Duolao;Phiri, Kamija;ter Kuile, Feiko O.; Published Date : Nov 06 2018 Source : Trials. 19. URL : https://stacks.cdc.gov/view/cdc/60734 Kwambai, Titus K. et al. (2018). Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial. 19 Kwambai, Titus K. et al. "Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial" 19 (2018) Kwambai, Titus K. et al. "Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial" vol. 19, 2018 Export RIS Citation Information.

:

Kwambai, Titus K. ;

Dhabangi, Aggrey

Nov 06 2018 | Trials. 19.

:

BackgroundChildren hospitalised with severe anaemia in malaria endemic areas in Africa are at high risk of readmission or death within 6 months post-...
Effect of Antibiotic-Mediated Microbiome Modulation on Rotavirus Vaccine Immunogenicity: A Human, Randomized-Control Proof-of-Concept Trial

CITE Title : Effect of Antibiotic-Mediated Microbiome Modulation on Rotavirus Vaccine Immunogenicity: A Human, Randomized-Control Proof-of-Concept Trial Personal Author(s) : Harris, Vanessa C.;Haak, Bastiaan W.;Handley, Scott A.;Jiang, Baoming;Velasquez, Daniel E.;Hykes, Barry L.;Droit, Lindsay;Berbers, Guy A.M.;Kemper, Elles Marleen;van Leeuwen, Ester M.M.;van Hensbroek, Michael Boele;Wiersinga, Willem Joost; Published Date : 8 08 2018;8-08-; Source : Cell Host Microbe. 24(2):197-207.e4 URL : https://stacks.cdc.gov/view/cdc/168747 Harris, Vanessa C. et al. (2018). Effect of Antibiotic-Mediated Microbiome Modulation on Rotavirus Vaccine Immunogenicity: A Human, Randomized-Control Proof-of-Concept Trial. 24(2). Harris, Vanessa C. et al. "Effect of Antibiotic-Mediated Microbiome Modulation on Rotavirus Vaccine Immunogenicity: A Human, Randomized-Control Proof-of-Concept Trial" 24, no. 2 (2018) Harris, Vanessa C. et al. "Effect of Antibiotic-Mediated Microbiome Modulation on Rotavirus Vaccine Immunogenicity: A Human, Randomized-Control Proof-of-Concept Trial" vol. 24, no. 2, 2018 Export RIS Citation Information.

:

Harris, Vanessa C. ;

Haak, Bastiaan W.

8 08 2018 | Cell Host Microbe. 24(2):197-207.e4

:

Rotavirus vaccines (RVV) protect against childhood gastroenteritis caused by rotavirus (RV) but have decreased effectiveness in low- and middle-income...